While both the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have released guidance on the ...

Advanced analytics leverages machine learning (ML), statistical modeling, data mining and visualizations to empower ...

Despite substantial advancements in the management of cardiogenic shock, mortality rates remain greater than 40%. Trials have ...

Background Current cardiovascular disease (CVD) risk prediction models tailored for older adults are inadequate. This study ...

Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...

Phenotypic variables such as smoking history and occupational exposures were significators predictors of head and neck cancer risk.